Copyright Reports & Markets. All rights reserved.

Global Devices for Inhaled Medications Market Research Report 2021

Request for Sample of this report
Buy now

1 Devices for Inhaled Medications Market Overview

  • 1.1 Product Overview and Scope of Devices for Inhaled Medications
  • 1.2 Devices for Inhaled Medications Segment by Type
    • 1.2.1 Global Devices for Inhaled Medications Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Dry Powder Inhalers
    • 1.2.3 Metered-Dose Inhalers
    • 1.2.4 Nebulizers
    • 1.2.5 Soft Mist Inhaler
  • 1.3 Devices for Inhaled Medications Segment by Application
    • 1.3.1 Devices for Inhaled Medications Sales Comparison by Application: (2021-2027)
    • 1.3.2 Clinic
    • 1.3.3 Hospital
    • 1.3.4 Home
  • 1.4 Global Devices for Inhaled Medications Market Size Estimates and Forecasts
    • 1.4.1 Global Devices for Inhaled Medications Revenue 2016-2027
    • 1.4.2 Global Devices for Inhaled Medications Sales 2016-2027
    • 1.4.3 Devices for Inhaled Medications Market Size by Region: 2016 Versus 2021 Versus 2027

2 Devices for Inhaled Medications Market Competition by Manufacturers

  • 2.1 Global Devices for Inhaled Medications Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Devices for Inhaled Medications Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Devices for Inhaled Medications Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Devices for Inhaled Medications Manufacturing Sites, Area Served, Product Type
  • 2.5 Devices for Inhaled Medications Market Competitive Situation and Trends
    • 2.5.1 Devices for Inhaled Medications Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Devices for Inhaled Medications Players Market Share by Revenue
    • 2.5.3 Global Devices for Inhaled Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Devices for Inhaled Medications Retrospective Market Scenario by Region

  • 3.1 Global Devices for Inhaled Medications Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Devices for Inhaled Medications Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Devices for Inhaled Medications Market Facts & Figures by Country
    • 3.3.1 North America Devices for Inhaled Medications Sales by Country
    • 3.3.2 North America Devices for Inhaled Medications Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Devices for Inhaled Medications Market Facts & Figures by Country
    • 3.4.1 Europe Devices for Inhaled Medications Sales by Country
    • 3.4.2 Europe Devices for Inhaled Medications Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Devices for Inhaled Medications Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Devices for Inhaled Medications Sales by Region
    • 3.5.2 Asia Pacific Devices for Inhaled Medications Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Devices for Inhaled Medications Market Facts & Figures by Country
    • 3.6.1 Latin America Devices for Inhaled Medications Sales by Country
    • 3.6.2 Latin America Devices for Inhaled Medications Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Devices for Inhaled Medications Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Devices for Inhaled Medications Sales by Country
    • 3.7.2 Middle East and Africa Devices for Inhaled Medications Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Devices for Inhaled Medications Historic Market Analysis by Type

  • 4.1 Global Devices for Inhaled Medications Sales Market Share by Type (2016-2021)
  • 4.2 Global Devices for Inhaled Medications Revenue Market Share by Type (2016-2021)
  • 4.3 Global Devices for Inhaled Medications Price by Type (2016-2021)

5 Global Devices for Inhaled Medications Historic Market Analysis by Application

  • 5.1 Global Devices for Inhaled Medications Sales Market Share by Application (2016-2021)
  • 5.2 Global Devices for Inhaled Medications Revenue Market Share by Application (2016-2021)
  • 5.3 Global Devices for Inhaled Medications Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Consort Medical
    • 6.1.1 Consort Medical Corporation Information
    • 6.1.2 Consort Medical Description and Business Overview
    • 6.1.3 Consort Medical Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Consort Medical Product Portfolio
    • 6.1.5 Consort Medical Recent Developments/Updates
  • 6.2 Inhalexper
    • 6.2.1 Inhalexper Corporation Information
    • 6.2.2 Inhalexper Description and Business Overview
    • 6.2.3 Inhalexper Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Inhalexper Product Portfolio
    • 6.2.5 Inhalexper Recent Developments/Updates
  • 6.3 Cambridge Consultants
    • 6.3.1 Cambridge Consultants Corporation Information
    • 6.3.2 Cambridge Consultants Description and Business Overview
    • 6.3.3 Cambridge Consultants Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Cambridge Consultants Product Portfolio
    • 6.3.5 Cambridge Consultants Recent Developments/Updates
  • 6.4 Hovione
    • 6.4.1 Hovione Corporation Information
    • 6.4.2 Hovione Description and Business Overview
    • 6.4.3 Hovione Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Hovione Product Portfolio
    • 6.4.5 Hovione Recent Developments/Updates
  • 6.5 Catalent, Inc
    • 6.5.1 Catalent, Inc Corporation Information
    • 6.5.2 Catalent, Inc Description and Business Overview
    • 6.5.3 Catalent, Inc Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Catalent, Inc Product Portfolio
    • 6.5.5 Catalent, Inc Recent Developments/Updates
  • 6.6 VertMarkets, Inc
    • 6.6.1 VertMarkets, Inc Corporation Information
    • 6.6.2 VertMarkets, Inc Description and Business Overview
    • 6.6.3 VertMarkets, Inc Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 VertMarkets, Inc Product Portfolio
    • 6.6.5 VertMarkets, Inc Recent Developments/Updates
  • 6.7 Qualicaps
    • 6.6.1 Qualicaps Corporation Information
    • 6.6.2 Qualicaps Description and Business Overview
    • 6.6.3 Qualicaps Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Qualicaps Product Portfolio
    • 6.7.5 Qualicaps Recent Developments/Updates
  • 6.8 3M
    • 6.8.1 3M Corporation Information
    • 6.8.2 3M Description and Business Overview
    • 6.8.3 3M Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 3M Product Portfolio
    • 6.8.5 3M Recent Developments/Updates
  • 6.9 Aerovance
    • 6.9.1 Aerovance Corporation Information
    • 6.9.2 Aerovance Description and Business Overview
    • 6.9.3 Aerovance Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Aerovance Product Portfolio
    • 6.9.5 Aerovance Recent Developments/Updates
  • 6.10 AstraZeneca
    • 6.10.1 AstraZeneca Corporation Information
    • 6.10.2 AstraZeneca Description and Business Overview
    • 6.10.3 AstraZeneca Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 AstraZeneca Product Portfolio
    • 6.10.5 AstraZeneca Recent Developments/Updates
  • 6.11 Boehringer Ingelheim
    • 6.11.1 Boehringer Ingelheim Corporation Information
    • 6.11.2 Boehringer Ingelheim Devices for Inhaled Medications Description and Business Overview
    • 6.11.3 Boehringer Ingelheim Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Boehringer Ingelheim Product Portfolio
    • 6.11.5 Boehringer Ingelheim Recent Developments/Updates
  • 6.12 Chiesi
    • 6.12.1 Chiesi Corporation Information
    • 6.12.2 Chiesi Devices for Inhaled Medications Description and Business Overview
    • 6.12.3 Chiesi Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Chiesi Product Portfolio
    • 6.12.5 Chiesi Recent Developments/Updates
  • 6.13 Cipla
    • 6.13.1 Cipla Corporation Information
    • 6.13.2 Cipla Devices for Inhaled Medications Description and Business Overview
    • 6.13.3 Cipla Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Cipla Product Portfolio
    • 6.13.5 Cipla Recent Developments/Updates
  • 6.14 Civitas/Alkermes
    • 6.14.1 Civitas/Alkermes Corporation Information
    • 6.14.2 Civitas/Alkermes Devices for Inhaled Medications Description and Business Overview
    • 6.14.3 Civitas/Alkermes Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Civitas/Alkermes Product Portfolio
    • 6.14.5 Civitas/Alkermes Recent Developments/Updates
  • 6.15 GlaxoSmithKline
    • 6.15.1 GlaxoSmithKline Corporation Information
    • 6.15.2 GlaxoSmithKline Devices for Inhaled Medications Description and Business Overview
    • 6.15.3 GlaxoSmithKline Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 GlaxoSmithKline Product Portfolio
    • 6.15.5 GlaxoSmithKline Recent Developments/Updates
  • 6.16 Hovione
    • 6.16.1 Hovione Corporation Information
    • 6.16.2 Hovione Devices for Inhaled Medications Description and Business Overview
    • 6.16.3 Hovione Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Hovione Product Portfolio
    • 6.16.5 Hovione Recent Developments/Updates
  • 6.17 Mannkind
    • 6.17.1 Mannkind Corporation Information
    • 6.17.2 Mannkind Devices for Inhaled Medications Description and Business Overview
    • 6.17.3 Mannkind Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Mannkind Product Portfolio
    • 6.17.5 Mannkind Recent Developments/Updates
  • 6.18 Mantecorp
    • 6.18.1 Mantecorp Corporation Information
    • 6.18.2 Mantecorp Devices for Inhaled Medications Description and Business Overview
    • 6.18.3 Mantecorp Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Mantecorp Product Portfolio
    • 6.18.5 Mantecorp Recent Developments/Updates
  • 6.19 Meda
    • 6.19.1 Meda Corporation Information
    • 6.19.2 Meda Devices for Inhaled Medications Description and Business Overview
    • 6.19.3 Meda Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Meda Product Portfolio
    • 6.19.5 Meda Recent Developments/Updates
  • 6.20 MicroDose Therapeutx
    • 6.20.1 MicroDose Therapeutx Corporation Information
    • 6.20.2 MicroDose Therapeutx Devices for Inhaled Medications Description and Business Overview
    • 6.20.3 MicroDose Therapeutx Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.20.4 MicroDose Therapeutx Product Portfolio
    • 6.20.5 MicroDose Therapeutx Recent Developments/Updates
  • 6.21 Novartis
    • 6.21.1 Novartis Corporation Information
    • 6.21.2 Novartis Devices for Inhaled Medications Description and Business Overview
    • 6.21.3 Novartis Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
    • 6.21.4 Novartis Product Portfolio
    • 6.21.5 Novartis Recent Developments/Updates

7 Devices for Inhaled Medications Manufacturing Cost Analysis

  • 7.1 Devices for Inhaled Medications Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Devices for Inhaled Medications
  • 7.4 Devices for Inhaled Medications Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Devices for Inhaled Medications Distributors List
  • 8.3 Devices for Inhaled Medications Customers

9 Devices for Inhaled Medications Market Dynamics

  • 9.1 Devices for Inhaled Medications Industry Trends
  • 9.2 Devices for Inhaled Medications Growth Drivers
  • 9.3 Devices for Inhaled Medications Market Challenges
  • 9.4 Devices for Inhaled Medications Market Restraints

10 Global Market Forecast

  • 10.1 Devices for Inhaled Medications Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Devices for Inhaled Medications by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Devices for Inhaled Medications by Type (2022-2027)
  • 10.2 Devices for Inhaled Medications Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Devices for Inhaled Medications by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Devices for Inhaled Medications by Application (2022-2027)
  • 10.3 Devices for Inhaled Medications Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Devices for Inhaled Medications by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Devices for Inhaled Medications by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Dry Powder Inhalers
    Metered-Dose Inhalers
    Nebulizers
    Soft Mist Inhaler

    Segment by Application
    Clinic
    Hospital
    Home

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Consort Medical
    Inhalexper
    Cambridge Consultants
    Hovione
    Catalent, Inc
    VertMarkets, Inc
    Qualicaps
    3M
    Aerovance
    AstraZeneca
    Boehringer Ingelheim
    Chiesi
    Cipla
    Civitas/Alkermes
    GlaxoSmithKline
    Hovione
    Mannkind
    Mantecorp
    Meda
    MicroDose Therapeutx
    Novartis

    Buy now